CCAPCrescent Capital BDC, Inc.(CCAP)Stock Analysis

AI analysis on 2,800+ stocks →
Nasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1633336CCAP stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

CCAP Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Crescent Capital BDC, Inc. (CCAP). CCAP is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), Crescent Capital BDC, Inc. reports net income of $-15.5M, free cash flow of $-23.8M. Top institutional holders of CCAP by reported 13-F value include Texas County & District Retirement System, Fidelity National Financial,, Blackstone, based on the most recent SEC filings. CCAP trades on the Nasdaq exchange and files with the SEC under CIK 1633336. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CCAP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Crescent Capital BDC, Inc. directly from SEC EDGAR.

Net Income

Q1 2026

$-15.5M

Free Cash Flow

Q1 2026

$-23.8M

ROIC

Q1 2026

-1.4%

D/E Ratio

Q1 2026

1.35

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Net Income

-53.1% YoY
$34.5MFY 2025
FY20 $54.7MFY23 $83.8MFY24 $73.6MFY25 $34.5M

Operating Income

+7.6% YoY
$-98.7MFY 2025
FY20 $-26.7MFY23 $-100.3MFY24 $-106.8MFY25 $-98.7M

EPS (Diluted)

-24.6% YoY
$1.81FY 2025
FY20 $1.80FY23 $2.30FY24 $2.40FY25 $1.81

Total Assets

-2.1% YoY
$1.62BFY 2025
FY20 FY23 $1.63BFY24 $1.66BFY25 $1.62B

Total Debt

-0.2% YoY
$873.8MFY 2025
FY20 FY23 $844.8MFY24 $875.8MFY25 $873.8M

Op. Cash Flow

+26.8% YoY
$74.7MFY 2025
FY20 $-61.8MFY23 $92.3MFY24 $58.9MFY25 $74.7M

AI Insight: CCAP Financial Trends

CCAP's profitability has collapsed into losses while leverage has risen sharply, signaling deteriorating credit quality.

Net income declined from $20M in Q2 2024 to -$16M in Q1 2026, turning negative for the first time.

Total debt rose to $907M in Q1 2026 from $880M in Q2 2024, while equity contracted to $674M from $752M.

Operating income remained persistently negative across all 9 quarters, ranging from -$22M to -$27M.

Debt-to-equity ratio deteriorated to 1.35x in Q1 2026 from 1.17x in Q2 2024 — critical for a BDC.

Operating cash flow has become unstable: -$24M in Q1 2026 after positive $31M in Q3 2025.

AI Insight: CCAP Ratio Trends

CCAP's returns have collapsed into negative territory in Q1 2026, with ROE plunging to -9.2% and ROIC remaining deeply negative at -5.5%.

ROE deteriorated sharply: 4.8% in Q4 2025 to -9.2% in Q1 2026, marking first negative quarterly return on equity.

ROA turned negative at -3.8% in Q1 2026 versus 2.1% in Q4 2025, indicating compressed profitability.

ROIC remained persistently negative across all periods, ranging -6.8% to -5.5%, with minimal improvement in latest quarter.

Leverage increased: D/E rose to 1.35 in Q1 2026 from 1.24 in Q4 2025, highest level in the series.

Sustained negative ROIC signals value destruction; BDC model may be under stress given persistent capital inefficiency.

Q1 2026 marks fourth consecutive quarter of single-digit or negative ROE; trend suggests structural profitability challenge.

Get alerted when CCAP's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Crescent Capital BDC, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of CCAP

Put CCAP on your watchlist

Track score changes the day Crescent Capital BDC, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CCAP a good stock to buy?

13F Pro's AI-powered analysis of Crescent Capital BDC, Inc. (CCAP) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CCAP are available on the CCAP stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CCAP?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CCAP. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Crescent Capital BDC, Inc.'s investment landscape.